Literature DB >> 35083547

Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.

Takashi Matsumoto1, Yuki Kitano1, Katsunori Imai1, Shotaro Kinoshita1, Hiroki Sato1, Yuta Shiraishi1, Kosuke Mima1, Hiromitsu Hayashi1, Yo-Ichi Yamashita1, Hideo Baba2.   

Abstract

PURPOSES: The present study investigated the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma (HCC) who underwent hepatectomy.
METHODS: In total, 493 patients diagnosed HCC using the Milan criteria who underwent hepatic resection were retrospectively analyzed. Patients were evaluated according to several prognostic nutrition indices. Univariate and multivariate analyses were performed to identify clinicopathological variables associated with the overall survival (OS).
RESULTS: According to a univariate analysis, higher values in the Glasgow Prognostic Score [GPS] (hazard ratio [HR] = 1.99, p = 0.002), modified GPS [mGPS] (HR = 2.26, p < 0.001), C-reactive protein [CRP]-to-albumin ratio [CAR] (HR = 1.86, p = 0.0012), and CONUT (HR = 1.65, p = 0.008) and a lower value of prognostic nutritional index [PNI] (HR = 2.36, p < 0.001) were significantly associated with a poor OS. A multivariate analysis showed that a CAR ≥ 0.037 (HR = 1.67, 95% CI 1.06-2.64, p = 0.03), FIB4-index > 3.25 (HR = 1.98, 95% confidence interval [CI] 1.25-3.14, p = 0.004) and PIVKA-II > 40 mAU/ml (HR = 1.72, 95% CI 1.14-2.61, p = 0.01) were independent prognostic factors.
CONCLUSIONS: This study demonstrated that the CAR was an independent prognostic score in patients with HCC and superior to other inflammation-based prognostic scores in terms of the prognosis.
© 2022. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  C-reactive protein–albumin ratio; Hepatocellular carcinoma; Inflammation score

Mesh:

Year:  2022        PMID: 35083547     DOI: 10.1007/s00595-021-02427-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  CONUT: a tool for controlling nutritional status. First validation in a hospital population.

Authors:  J Ignacio de Ulíbarri; A González-Madroño; N G P de Villar; P González; B González; A Mancha; F Rodríguez; G Fernández
Journal:  Nutr Hosp       Date:  2005 Jan-Feb       Impact factor: 1.057

Review 2.  Cancer-induced cachexia: a guide for the oncologist.

Authors:  Norleena Gullett; Peter Rossi; Omer Kucuk; Peter A S Johnstone
Journal:  J Soc Integr Oncol       Date:  2009

3.  Lysis of tumor cells by natural killer cells in mice is impeded by platelets.

Authors:  B Nieswandt; M Hafner; B Echtenacher; D N Männel
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

4.  The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer.

Authors:  G Kasymjanova; N MacDonald; J S Agulnik; V Cohen; C Pepe; H Kreisman; R Sharma; D Small
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

5.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.